Previous Article | Next Article ![]()
Journal of Virology, January 1999, p. 801-804, Vol. 73, No. 1
Unité des Virus Lents, ERS 572 CNRS,
Institut Pasteur, 75724 Paris Cedex 15, France,1
and
Institute of Poliomyelitis and Viral Encephalitides,
Moscow Region 142782, Russia2
Received 10 July 1998/Accepted 23 September 1998
The DA strain of Theiler's virus causes a persistent and
demyelinating infection of the white matter of spinal cord, whereas the
GDVII strain causes a fatal gray-matter encephalomyelitis. Studies with
recombinant viruses showed that this difference in phenotype is
controlled mainly by the capsid. However, conflicting results regarding
the existence of determinants of persistence in the capsid of the GDVII
strain have been published. Here we show that a GDVII virus whose
neurovirulence has been attenuated by an insertion in the 5' noncoding
region does not persist in the central nervous systems of mice.
Furthermore, this virus infects the gray matter efficiently, but not
the white matter. These results confirm the absence of determinants of
persistence in the GDVII capsid. They suggest that the DA capsid
controls persistence by allowing the virus to infect cells in the white
matter of the spinal cord.
Theiler's virus is a murine
picornavirus related to encephalomyocarditis virus and Mengo virus, two
members of the Cardiovirus genus. Although all strains of
Theiler's virus are closely related, serologically and at the nucleic
acid sequence level (17, 19, 20, 22), they can be divided
into two groups based on the disease they cause after intracranial
inoculation. Most strains, including the DA and BeAn strains, cause a
biphasic disease of the central nervous system (CNS) (13).
The first phase, or early disease, is an acute encephalomyelitis which
occurs during the first days following inoculation. During this period,
the virus infects mainly neurons in the gray matter of the brain and
spinal cord. Most animals survive and enter the second phase of the
disease, during which the virus persists in the white matter of the
spinal cord, mainly in macrophages and oligodendrocytes (2, 15, 21). Viral persistence is associated with focal inflammatory lesions in which numerous demyelinated axons can be seen (6, 13). Persistence and late disease occur only in genetically susceptible mouse strains, such as the SJL/J strain (3).
Resistant strains clear the infection at the end of the early phase of
the disease, mainly through a vigorous, class I-restricted, cytotoxic T-lymphocyte response (7, 11). Accordingly, the nude
mutation confers susceptibility on mice with an otherwise resistant
background (26, 29). In contrast to the DA and BeAn strains,
strain GDVII is highly neurovirulent. It replicates permissively in
neurons during the early phase, killing its host in a matter of days
(27). Based on the observation that the GDVII strain does
not persist in the rare survivors (12), determinants of
persistence have been mapped by recombining cDNA obtained from the DA
(or BeAn) and GDVII strains. The results obtained by different groups
are, on the whole, consistent and show that the capsids of the DA and BeAn strains contain the main determinants of persistence (1, 16). However, some studies with recombinant viruses suggested that determinants of persistence were also present on the capsid of the
GDVII strain (8, 25), an observation which, if confirmed, would make the interpretation of the phenotype of recombinant viruses
very difficult.
The persistence of GDVII virus is difficult to assess directly since
the virus kills the majority of mice within the first week
postinoculation. Therefore, attenuated GDVII viruses are invaluable for
investigation of the question. Variants in which attenuation is due to
modifications in the cis-acting control elements of the 5'
noncoding region are particularly suitable for this purpose since the
rest of the genome, including the region coding for the capsid
proteins, consists of GDVII sequences (24). In this study we
made use of mutant GD-43 (formerly GD/I.27-43) (23), which
harbors an engineered 27-nucleotide-long insertion just upstream of the
initiator codon. This insertion contains an AUG in a nonoptimal context
(uauAUGu), followed by a stop codon 3 nucleotides further
down. While being attenuated for mice, GD-43 exhibits an almost
wild-type phenotype in BHK-21 cells (23, 24).
We tested the ability of virus GD-43 to persist in the CNS of
susceptible inbred SJL/J mice. Eighteen 3-week-old SJL/J mice were
inoculated intracerebrally with 40 µl of phosphate-buffered saline
containing 105 PFU of GD-43 virus and sacrificed at days 6, 14, 22, and 45 postinoculation. The CNS was removed and studied for
histopathology and for the presence of viral antigen, as described in a
previous publication (2). In the four mice which were
analyzed 6 days postinoculation, viral antigen and numerous foci of
inflammation were found in the gray matter of the CNS. Most infected
cells had the morphology of neurons (Fig.
1), as already reported for the early
phase of infection with the DA or GDVII virus. A minority of infected
cells could not be identified by morphological criteria, mainly because of cytopathic effect. Four mice were sacrificed 14 days
postinoculation. A small number of infected cells were observed in the
gray matter of the brain and spinal cord of one mouse, which was
paralyzed, whereas no viral antigen was found in the other three mice.
Five mice were sacrificed 22 days postinoculation, and another five were sacrificed 45 days postinoculation. No viral antigen could be
detected in the CNS of any of the 10 animals. However, some inflammation was observed in the white matter of the spinal cord, mainly in some of the mice sacrificed 22 days postinoculation.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
An Attenuated Variant of the GDVII Strain of
Theiler's Virus Does Not Persist and Does Not Infect the White
Matter of the Central Nervous System

![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (128K):
[in a new window]
FIG. 1.
Histological findings in the brain of an SJL/J mouse 6 days after inoculation with virus GD-43. Viral capsid antigens were
detected by immunocytochemistry with a rabbit hyperimmune serum. The
arrow points to infected neurons. Magnification, ×312.
We then compared the levels of viral RNA present in the CNS of GD-43- and DA-infected SJL/J mice, 45 days after inoculation. Two groups of SJL/J mice were inoculated with 105 PFU of GD-43 or DA virus and sacrificed 45 days postinoculation. Total brain and spinal cord RNA was extracted by the method of Chomczynski and Sacchi (5), and viral RNA was quantitated by dot blot hybridization as described elsewhere (4). Briefly, a series of fivefold dilutions of total RNA was dotted on a Hybond C+ membrane, starting with 10 µg of total RNA per dot, and hybridized with a radioactive probe consisting of nucleotides 5428 to 6944 of the GDVII genome labeled with 32P (5 × 107 dpm/µg) by random priming. No viral RNA could be detected in the spinal cords or the brains of the GD-43-infected mice. As expected, all the DA-infected mice had viral RNA, mainly in their spinal cords (Fig. 2). In conclusion, both the histological and dot blot analyses showed that virus GD-43 doesn't persist in the CNS of susceptible SJL/J mice.
|
The DA and BeAn strains of Theiler's virus infect the gray and white matter of the CNS successively. Our previous studies indicated that modifications of the DA capsid alter the tropism of the virus for the white matter (9). We hypothesized that only those strains able to infect white-matter cells may persist. However, because the strain is highly virulent, the tropism of the GDVII virus is difficult to study at late times postinoculation. On the other hand, the GD-43 virus, an attenuated Theiler's virus with a GDVII capsid, offers the possibility of examining this point. To perform this study under stringent conditions, we used nude mice which, because they are immunocompromised, remain persistently infected even when inoculated with a nonpersisting recombinant Theiler's virus (9). Groups of 4-week-old BALB/c nu/nu mice were inoculated with 102 or 104 PFU of DA or GD-43 virus and sacrificed at various times after inoculation for histological analysis of the CNS. Most mice inoculated with 104 PFU of either virus presented with severe signs of encephalitis and were sacrificed between days 13 and 17 postinoculation. The majority of mice inoculated with 102 PFU survived longer and could be examined at 21 days postinoculation. Antigen-positive cells were found in the gray matter of the brain in both DA- and GD-43-infected mice. In the spinal cord, on the other hand, the pattern of infection depended on the virus (Fig. 3). Ten mice inoculated with virus DA were analyzed 13 or 15 days postinoculation, and five mice were analyzed 21 days postinoculation. At 13 to 15 days postinoculation, the number of infected cells in the white matter was similar to, or greater than, the number of infected cells in the gray matter. Figure 3A illustrates the presence of viral antigen in the white matter at this time. At 21 days postinoculation, a large number of virus-infected cells were found in the white matter and only a small number were found in the gray matter (Fig. 3B). Six mice inoculated with virus GD-43 were analyzed between days 13 and 17 postinoculation, and five mice were analyzed at day 21 postinoculation. In contrast to the findings with virus DA, only a few antigen-positive cells were found in the white matter and they were present in some mice only. Almost all infected cells were in the gray matter at both 13 to 15 (Fig. 3C) and 21 (Fig. 3D) days postinoculation. Most of these cells could be identified as neurons by their morphology. The difference in localization of the GDVII and GD-43 viruses was documented further by counting the number of infected cells in the gray and white matter of the spinal cord 21 days postinoculation. Two longitudinal sections of the entire spinal cords of four BALB/c nu/nu mice inoculated with 102 PFU of either virus were systematically scanned under a microscope, and viral antigen-positive cells in gray and white matter were counted (Table 1). On average, 93% of DA virus-infected cells were in the white matter and 95% of GD-43 virus-infected cells were in the gray matter.
|
|
In the present work, we show that an attenuated GDVII virus doesn't persist in the CNS of SJL/J mice. Our findings are in complete agreement with those recently reported by Lipton et al. (14). Those authors attenuated the GDVII virus either by exchanging part of the 5' noncoding region with that of the BeAn virus or by deleting part of the L gene. These attenuated viruses did not persist in SJL/J mice. Thus, it is now clear that the capsid of virus GDVII does not contain determinants that would lead to a persistent infection if the animals were to survive. Previous results suggesting that the capsids of both DA and GDVII viruses contain determinants of persistence (8, 25) might be explained by the difficulties encountered in interpreting the phenotype of recombinant viruses with hybrid capsids. More than a specific linear sequence of amino acids, persistence may require conformational determinants in a region made of the VP2 "puff" and the VP1 CD loop (1, 10, 28, 30). Our results indicate that these determinants might be absent from the native GDVII capsid.
The DA and BeAn viruses persist in macrophages and oligodendrocytes in the white matter of the spinal cord (2, 15, 21). Here we report that the nonpersistent GD-43 virus doesn't efficiently infect the white matter of the spinal cord. These results, and our previous findings with recombinant viruses (9), suggest that the capsid may control persistence by determining the tropism of the virus for glial cells of the white matter of the spinal cord. The conformation of the capsid may enable the virus to interact with a specific receptor on these cells. Interestingly, recent results suggest that the persistent BeAn strain binds to the cell surface differently than the GDVII virus (28). Obviously, other mechanisms by which the capsid controls persistence can be envisioned, such as via a role in virus transport within the CNS.
Some inflammation was found in the white matter of the spinal cord in SJL/J mice infected with the GD-43 virus, although the virus was restricted to the gray matter. Miller et al. showed that T-cell responses to myelin epitopes arise during persistent infection with Theiler's virus (18). It would be interesting to determine whether inflammation in the white matter of GD-43-infected mice corresponds to the presence of autoreactive T cells.
In conclusion, we report that an attenuated GDVII virus does not persist in the CNS of susceptible SJL/J mice and does not efficiently infect the white matter of the spinal cord in both SJL/J and immunodeficient BALB/c nu/nu mice. These results confirm that attenuation of the neurovirulence of the GDVII virus is not sufficient to allow the virus to persist in the CNS. They suggest that the capsids of the DA and BeAn viruses determine persistence by allowing the virus to infect glial cells in the white matter of the spinal cord.
| |
ACKNOWLEDGMENTS |
|---|
We thank Sylvie Syan for expert technical assistance and Mireille Gau for preparing the manuscript.
This work was supported by grants from the Institut Pasteur Foundation, the Centre National de la Recherche Scientifique, the EC Human Capital and Mobility Program (contract no. CHRX-CT94-0670), and the Russian Foundation for Basic Research (grants 96-04-48131 and 96-15-97867). During part of this work, E.G.V. was supported by a grant from the French Embassy in Moscow.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Unité des Virus Lents, ERS 572 CNRS, Institut Pasteur, 75724 Paris Cedex 15, France. Phone: 33 1 45 68 87 70. Fax: 33 1 40 61 31 67. E-mail: mbrahic{at}pasteur.fr.
Present address: Hormone Research Institute, University of
California San Francisco, San Francisco, CA 94143-0534.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Adami, C.,
A. E. Pritchard,
T. Knauf,
M. Luo, and H. L. Lipton.
1998.
A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses.
J. Virol.
72:1662-1665 |
| 2. | Aubert, C., M. Chamorro, and M. Brahic. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3:319-326[Medline]. |
| 3. | Brahic, M., and J. F. Bureau. 1998. Genetics of susceptibility to Theiler's virus infection. Bioessays 20:627-633[Medline]. |
| 4. |
Bureau, J. F.,
X. Montagutelli,
S. Lefebvre,
J.-L. Guénet,
M. Pla, and M. Brahic.
1992.
The interaction of two groups of murine genes controls the persistence of Theiler's virus in the central nervous system.
J. Virol.
66:4698-4704 |
| 5. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 6. | Daniels, J. B., A. M. Pappenheimer, and S. Richardson. 1952. Observations on encephalomyelitis of mice (DA strain). J. Exp. Med. 96:22-24. |
| 7. | Dethlefs, S., M. Brahic, and E. L. Larsson-Sciard. 1997. An early abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. J. Virol. 71:8875-8878[Abstract]. |
| 8. |
Fu, J.,
M. Rodriguez, and R. P. Roos.
1990.
Strains from both Theiler's virus subgroups encode a determinant for demyelination.
J. Virol.
64:6345-6348 |
| 9. |
Jarousse, N.,
L. Fiette,
R. A. Grant,
J. M. Hogle,
A. McAllister,
T. Michiels,
C. Aubert,
M. Brahic, and C. Pena Rossi.
1994.
Chimeric Theiler's virus with altered tropism for the central nervous system.
J. Virol.
68:2781-2786 |
| 10. |
Jarousse, N.,
R. A. Grant,
J. M. Hogle,
L. Zhang,
A. Senkowski,
R. P. Roos,
T. Michiels,
M. Brahic, and A. McAllister.
1994.
A single amino acid change determines persistence of a chimeric Theiler's virus.
J. Virol.
68:3364-3368 |
| 11. |
Lindsley, M. D.,
R. Thiemann, and M. Rodriguez.
1991.
Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.
J. Virol.
65:6612-6620 |
| 12. |
Lipton, H. L.
1980.
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size.
J. Gen. Virol.
46:169-177 |
| 13. |
Lipton, H. L.
1975.
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.
Infect. Immun.
11:1147-1155 |
| 14. | Lipton, H. L., A. E. Pritchard, and M. A. Calenoff. 1998. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system. J. Gen. Virol. 79:1001-1004[Abstract]. |
| 15. | Lipton, H. L., G. Twaddle, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:2525-2533[Abstract]. |
| 16. |
McAllister, A.,
F. Tangy,
C. Aubert, and M. Brahic.
1990.
Genetic mapping of the ability of Theiler's virus to persist and demyelinate.
J. Virol.
64:4252-4257 |
| 17. | Michiels, T., N. Jarousse, and M. Brahic. 1995. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 214:550-558[Medline]. |
| 18. | Miller, S. D., C. L. Vanderlugt, W. Smith Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, and B. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-1136[Medline]. |
| 19. | Ohara, Y., S. Stein, J. Fu, L. Stillman, L. Klaman, and R. P. Roos. 1988. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164:245-255[Medline]. |
| 20. |
Ozden, S.,
F. Tangy,
M. Chamorro, and M. Brahic.
1986.
Theiler's virus genome is closely related to that of encephalomyocarditis virus, the prototype cardiovirus.
J. Virol.
60:1163-1165 |
| 21. | Pena Rossi, C., M. Delcroix, I. Huitinga, A. McAllister, N. Van Rooijen, E. Claassen, and M. Brahic. 1997. Role of macrophages during Theiler's virus infection. J. Virol. 71:3336-3340[Abstract]. |
| 22. |
Pevear, D. C.,
M. Calenoff,
E. Rozhon, and H. L. Lipton.
1987.
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses.
J. Virol.
61:1507-1516 |
| 23. | Pilipenko, E. V., A. P. Gmyl, S. V. Maslova, G. A. Belov, A. N. Sinyakov, M. Huang, T. D. K. Brown, and V. I. Agol. 1994. Starting window, a distinct element in the cap-independent internal initiation of translation on picornaviral RNA. J. Mol. Biol. 241:398-414[Medline]. |
| 24. | Pilipenko, E. V., A. P. Gmyl, S. V. Masvola, E. V. Khitrina, and V. I. Agol. 1995. Attenuation of Theiler's murine encephalomyelitis virus by modifications of the oligopyrimidine/AUG tandem, a host dependent translational cis element. J. Virol. 69:864-870[Abstract]. |
| 25. |
Rodriguez, M., and R. P. Roos.
1992.
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses.
J. Virol.
66:217-225 |
| 26. | Roos, R. P., and R. Wollmann. 1984. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 15:494-499[Medline]. |
| 27. | Theiler, M. 1937. Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 55:705-719. |
| 28. | Zhou, L., X. Lin, T. J. Gree, H. L. Lipton, and M. L. Luo. 1997. Role of sialyloligosaccharide binding in Theiler's virus persistence. J. Virol. 71:9701-9712[Abstract]. |
| 29. |
Zurbriggen, A., and R. S. Fujinami.
1988.
Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells.
J. Virol.
62:3589-3596 |
| 30. |
Zurbriggen, A.,
C. Thomas,
M. Yamada,
R. P. Roos, and R. S. Fujinami.
1991.
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection.
J. Virol.
65:1929-1937 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»